Drug
sacituzumab govitecan
Marketed as TRODELVY.
Generic name
sacituzumab govitecan
Brand names
TRODELVY
First FDA approval
2020-04-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761115 | TRODELVY | 2020-04-22 | IMMUNOMEDICS INC |
Manufacturers
IMMUNOMEDICS INC
Frequently asked questions
When was sacituzumab govitecan FDA approved?
Earliest FDA approval on record: 2020-04-22.
What brand names are sold as sacituzumab govitecan?
TRODELVY.
Sources
Appeal a sacituzumab govitecan denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com